Obinutuzumab
Acalabrutinib
Zanubrutinib
Update Venetoclax in CLL
Leukemia & Lymphoma Society
ASCO: COVID-19 Medical Resources
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
UpToDate